Related Experiment Video
Updated: Sep 17, 2025

06:34
An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
36.5K
Summary
A single injection of a new long-acting influenza treatment provided complete protection against the flu for a full season in a large study. This innovative vaccine offers extended immunity, simplifying seasonal flu prevention.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Seasonal influenza poses a significant global health burden, necessitating effective and convenient preventive measures.
- Current influenza vaccines require annual administration, presenting challenges for widespread compliance and consistent protection.
Discussion:
- This study evaluated a novel long-lasting injectable influenza treatment designed for extended seasonal protection.
- The research assessed the efficacy and safety of a single-dose formulation against circulating influenza strains.
Key Insights:
- A single administration of the long-lasting influenza treatment conferred protection throughout an entire influenza season.
- The findings suggest a potential paradigm shift in influenza vaccination strategies, moving towards less frequent administration.
Outlook:
- Further research should focus on long-term immunogenicity and broad-spectrum protection against diverse influenza strains.
- This long-acting formulation could enhance public health outcomes by improving influenza vaccine uptake and adherence.
More Related Videos
Related Concept Videos
Vaccinations
45.3K
Overview
45.3K
Cross-reactivity
31.5K
Overview
31.5K
Dose-Response Relationship: Potency and Efficacy
5.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.2K

